Llwytho...
ACS Chemical Neuroscience Molecule Spotlight on Lorcaserin
[Image: see text] Lorcaserin (APD-356) is the first in a new class of selective serotonin 5-hydroxytryptamine(2C) (5-HT(2C)) receptor agonists. On December 22, 2009, the compound's developer (Arena Pharmaceuticals) submitted an NDA to the FDA for approval for weight management.
Wedi'i Gadw mewn:
| Prif Awdur: | |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
American Chemical Society
2010
|
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3368635/ https://ncbi.nlm.nih.gov/pubmed/22778808 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/cn100059u |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|